Response to breast neoadjuvant systemic therapy (NAST) was longitudinaly monitored with Diffustion Tensor Imaging (DTI) pre and post therapy and evaluated in reference to post surgery histopatholgy results. A correlation was demonstrated between DTI residual tumor size and pathology size. Response in the various breast cancer subtypes was revealed by increased λ 1 values validated by a correlation with the pathological residual disease. DTI detected pCR in all breast subtypes with a good sensitivity and specificity
This abstract and the presentation materials are available to members only; a login is required.